The largest database of trusted experimental protocols

4 protocols using cd45 apc h7 clone 2d1

1

Evaluating T Cell Proliferation by CFSE Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The proliferation of T cells was quantified by CFSE dilution. Isolated PBMCs were labeled with 2 μM carboxyfluorescein diacetate succinimidyl ester (CFSE; CellTrace CFSE Cell Proliferation Kit, Thermo Fisher Scientific). CFSE-labeled PBMCs (1 × 105/well) were cultured in 96 well plate with or without EVs (4 μg) derived from naive or TSG primed WJ-MSCs, in the presence of anti-CD3/CD28 microbeads (Gibco) and recombinant human IL-2 (30 U/mL, Peprotech). After 6 days of incubation, the cells were stained with human monoclonal antibodies against CD45-APC-H7 (clone 2D1), CD3-PE-Cy5 (clone HIT3α), CD4-FITC (clone RPA-T4), and CD8-BV421 (clone RPA-T8, BD Biosciences) and measured by flow cytometry. All cells were gated on 7AAD negative cells.
+ Open protocol
+ Expand
2

Characterization of Granulocytic MDSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For both patients and healthy donors, granulocytes and PBMCs were freshly obtained from 3 ml of whole blood, collected in EDTA and rigorously processed within 2 hours over centrifugation on Ficoll-Paque solution (GE Healthcare Life Sciences, Cleveland, Ohio), according to manufacturer's protocol. G-MDSCs were identified in PBMCs based on the lack of HLA-DR, the dim CD33 staining, and the expression of CD66b, with CD11b and CD16 being used to differentiate between immature (CD11b and CD16), intermediate (CD11b+/CD16) and mature (CD11b+CD16+) subsets (16). PBMCs (0.5 × 106 cells/tube) were stained for 15 minutes with: CD16 PerCP-Cy5.5 (clone 3G8), CD33 PE-Cy7 (clone P67.6), CD11b APC (clone D12), HLA-DR PE (clone L243), and CD45 APC-H7 (clone 2D1) all from BD Biosciences (Becton, Dickinson and Company, Franklin Lakes, New Jersey) and with CD66b FITC (clone g10f5, BioLegend, San Diego, CA).
Fluorescence acquisition was performed using a FACS Canto flow cytometer (Becton, Dickinson and Company, New Jersey): it was considered reliable when at least 0.25 × 106 CD45+ events were recorded. The analysis of flow cytometric data was performed using FlowJo software (Tree Star, Inc. Ashland, OR).
+ Open protocol
+ Expand
3

Evaluation of Platelet Phenotype in HD and TB

Check if the same lab product or an alternative is used in the 5 most similar protocols
The evaluation of platelets phenotype was performed on HD and active TB using anti‐human mAbs to CD61 PerCP (Clone RUU‐PL7F12), CD62p PE (clone AC1.2), CD42b APC (clone HIP1), CD41a FITC (clone HIP8), CD42a PE (clone ALMA.16), PAC‐1 FITC (clone PAC‐1), and CD45 APC‐H7 (clone 2D1), all from BD Bioscience (San Diego, USA) and the relative isotype controls [57 (link), 58 (link)]. For the surface staining, 20 μL of platelets was used for a tube containing 20 μL of each mAb used in different combinations. After 20 min of incubation at room temperature, the samples were resuspended in PBS acquired using a FACSCANTO II (BD Biosciences). FACS plots were analyzed using FlowJo software (version 6.1.1; Tree Star, Ashland, OR, USA). The sequential gating strategy is shown in Supporting information Fig. S7.
+ Open protocol
+ Expand
4

Multiparameter Immunophenotyping of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following anti-human antibodies were used for staining of cytobrush and whole blood samples: CD3-Pacific Blue (clone UCHT1, BD), CD4-PerCP Cy5.5 (clone OKT4, eBioscience), CD8-Horizon-V500 (clone RPA-T, BD), CD45-APC-H7 (clone 2D1, BD), CD45RO-PE (clone UCHL1, BD), HLA-DR-APC (cloneG46-6 BD-Pharmingen) (only for cytobrush samples), α4β7-FITC (clone FIB504, Biolegend), and CCR5-PEcy7 (clone 2D7/CCR5, BD). Cells were incubated with the antibody cocktail at 4°C for 30 minutes in the dark, washed with FACS wash buffer (PBS with 1% bovine serum albumin and 0.05% sodium azide), and acquired on a FACS Canto II (BD) after fixation with 2% paraformaldehyde in water. Only cervical cytobrush samples without visible red blood cells, satisfactory staining quality, and T-cell counts above 150 cells were included in the analysis. For whole blood, a cut-off of at least 10,000 lymphocyte events was applied. Fluorescent spill over compensation was conducted with antibody capture beads (BD) stained separately with the individual antibodies used in the test samples. Gating was guided for both sample types (peripheral blood and cytobrush) separately by fluorescence minus one (FMO) controls. Flow cytometry data was processed using FlowJo version 10.4 (Tree Star Inc.).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!